Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cue Biopharma Inc buy Stifel Nicolaus

Start price
€3.00
22.03.23 / 50%
Target price
€7.41
22.03.24
Performance (%)
-42.17%
End price
€1.74
23.03.24
Summary
This prediction ended on 23.03.24 with a price of €1.74. Massive losses of -42.17% were the result for the BUY prediction by Stifel_Nicolaus. Stifel_Nicolaus has a follow-up prediction for Cue Biopharma Inc where he still thinks Cue Biopharma Inc is a Buy. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cue Biopharma Inc -20.112% -20.112% -63.333%
iShares Core DAX® 1.851% 5.158% 17.711%
iShares Nasdaq 100 1.573% 2.589% 39.053%
iShares Nikkei 225® -0.412% -2.857% 13.501%
iShares S&P 500 1.128% 2.485% 29.871%

Comments by Stifel_Nicolaus for this prediction

In the thread Cue Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -42.17%
Target price 7.412
Change
Ends at 22.03.24

Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat

In the thread Trading Cue Biopharma Inc
Prediction Buy
Perf. (%) -42.17%
Target price 7.412
Change
Ends at 22.03.24

Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten

Current prediction by Stifel_Nicolaus for Cue Biopharma Inc

buy
Cue Biopharma Inc

Start price
Target price
Perf. (%)
€1.65
09.04.24
€7.35
09.04.25
-13.33%
14.05.24